64 related articles for article (PubMed ID: 18467270)
41. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
Brito D; Richard P; Komajda M; Madeira H
Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
[TBL] [Abstract][Full Text] [Related]
42. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
43. [FTIR spectroscopic characterization of freshly removed breast cancer tissues].
Zhou S; Xu Z; Ling XF; Li QB; Xu YZ; Zhang L; Zhao HM; Wang LX; Hou KY; Zhou XS; Wu JG
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):512-4. PubMed ID: 17147115
[TBL] [Abstract][Full Text] [Related]
44. E-cadherin negative primary small cell carcinoma of the breast.
Adegbola T; Connolly CE; Mortimer G
Am J Clin Pathol; 2005 May; 123(5):788. PubMed ID: 15981821
[No Abstract] [Full Text] [Related]
45. Cancer of the breast; second statistical report of results.
TRUEBLOOD DV
West J Surg Obstet Gynecol; 1954 Nov; 62(11):571-3. PubMed ID: 13217251
[No Abstract] [Full Text] [Related]
46. BREAST MALIGNANCIES.
FLORENDO F
Philipp J Surg Surg Spec; 1964; 19():305-9. PubMed ID: 14216813
[No Abstract] [Full Text] [Related]
47. The molecular pathology of hereditary breast cancer.
Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
[TBL] [Abstract][Full Text] [Related]
48. Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked?
Slee PH; van der Waal RI; Schagen van Leeuwen JH; Tupker RA; Timmer R; Seldenrijk CA; van Steensel MA
Br J Dermatol; 2007 Dec; 157(6):1087-92. PubMed ID: 17941940
[TBL] [Abstract][Full Text] [Related]
49. E-cadherin expression in invasive breast cancer.
Suciu C; Cîmpean AM; Mureşan AM; Izvernariu D; Raica M
Rom J Morphol Embryol; 2008; 49(4):517-23. PubMed ID: 19050801
[TBL] [Abstract][Full Text] [Related]
50. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
Qureshi HS; Linden MD; Divine G; Raju UB
Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
[TBL] [Abstract][Full Text] [Related]
51. E-cadherin and fibronectin expressions have no prognostic role in stage II ductal breast cancer.
Swiatoniowski G; Matkowski R; Suder E; Bruzewicz S; Setta M; Kornafel J; Polozowski A; Surowiak P
Anticancer Res; 2005; 25(4):2879-83. PubMed ID: 16080541
[TBL] [Abstract][Full Text] [Related]
52. [Importance of E-cadherin; expression in the inmunohistochemical diagnosis of breast cancer].
García Tamayo J; Blasco Olaetxea E; Morales A; Molina J; Guzmán Bistoni C; Méndez V
Invest Clin; 2006 Dec; 47(4):371-83. PubMed ID: 17176905
[TBL] [Abstract][Full Text] [Related]
53. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history.
Bruzewicz S; Matkowski R; Swiatoniowski G; Suder E; Setta M; Połozowski A; Zychowicz K; Szynglarewicz B; Kornafel J
Adv Med Sci; 2008; 53(2):251-5. PubMed ID: 18467270
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
